Your browser doesn't support javascript.
loading
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.
Hasim, Mohamed S; Marotel, Marie; Hodgins, Jonathan J; Vulpis, Elisabetta; Makinson, Olivia J; Asif, Sara; Shih, Han-Yu; Scheer, Amit K; MacMillan, Olivia; Alonso, Felipe G; Burke, Kelly P; Cook, David P; Li, Rui; Petrucci, Maria Teresa; Santoni, Angela; Fallon, Padraic G; Sharpe, Arlene H; Sciumè, Giuseppe; Veillette, André; Zingoni, Alessandra; Gray, Douglas A; McCurdy, Arleigh; Ardolino, Michele.
Afiliação
  • Hasim MS; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Marotel M; CI3, University of Ottawa, Ottawa, ON, Canada.
  • Hodgins JJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Vulpis E; CI3, University of Ottawa, Ottawa, ON, Canada.
  • Makinson OJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Asif S; CI3, University of Ottawa, Ottawa, ON, Canada.
  • Shih HY; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Scheer AK; Department of Molecular Medicine, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci-Bolognetti, Rome, Italy.
  • MacMillan O; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Alonso FG; CI3, University of Ottawa, Ottawa, ON, Canada.
  • Burke KP; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Cook DP; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Li R; CI3, University of Ottawa, Ottawa, ON, Canada.
  • Petrucci MT; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Santoni A; Neuro-Immune Regulome Unit, National Eye Institute, NIH, Bethesda, MD, USA.
  • Fallon PG; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Sharpe AH; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Sciumè G; CI3, University of Ottawa, Ottawa, ON, Canada.
  • Veillette A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Zingoni A; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Gray DA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
  • McCurdy A; Harvard Medical School, Boston, MA, USA.
  • Ardolino M; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Sci Adv ; 8(15): eabj3286, 2022 04 15.
Article em En | MEDLINE | ID: mdl-35417234
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Neoplasias Limite: Animals / Humans Idioma: En Revista: Sci Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Neoplasias Limite: Animals / Humans Idioma: En Revista: Sci Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá